CAR-T immunotherapy for prostate cancer?

The specialized cells of our immune systems help to keep us healthy and free of infectious diseases. Immunotherapies teach those same cells to recognize and destroy cancer. Researchers are reporting promising results with a different method that involves engineered cells studded with receptors that bind to specific targets on cancer cells.

Content restricted. Requires subscription

CGRP inhibitors provide new options for migraine treatment

Based on that research, the U.S. Food and Drug Administration (FDA) has approved two different types of migraine therapies targeting CGRP.  The first CRGP inhibitors were designed as preventive therapy to reduce both the frequency and severity of migraine attacks. Since then, the FDA has also approved drugs to help stop or greatly reduce the symptoms of an acute headache. Here's what you should know if you're considering trying CGRP inhibitors. 

Content restricted. Requires subscription